Third Harmonic Bio, Inc. financial data

Symbol
THRD on Nasdaq
Location
1700 Montgomery Street, Suite 210, San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 4.4K % -21.4%
Debt-to-equity 3.2 % +5.62%
Return On Equity -19.3 % -76.4%
Return On Assets -18.7 % -76.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.1M shares +10.8%
Common Stock, Shares, Outstanding 45M shares +11.7%
Entity Public Float 299M USD +247%
Common Stock, Value, Issued 5K USD +25%
Weighted Average Number of Shares Outstanding, Basic 44.9M shares +11.7%
Weighted Average Number of Shares Outstanding, Diluted 44.9M shares +11.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 40.9M USD +74.5%
General and Administrative Expense 25.4M USD +28.2%
Operating Income (Loss) -66.3M USD -53.3%
Nonoperating Income (Expense) 12.9M USD -5.93%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -53.4M USD -80.6%
Earnings Per Share, Basic 1 USD/shares +65.3%
Earnings Per Share, Diluted 1 USD/shares +65.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 272M USD +3.34%
Assets, Current 276M USD +3.92%
Deferred Income Tax Assets, Net 38.2M USD +49.8%
Property, Plant and Equipment, Net 117K USD -25.5%
Operating Lease, Right-of-Use Asset 2.85M USD -20.7%
Other Assets, Noncurrent 414K USD -42.9%
Assets 280M USD +3.44%
Accounts Payable, Current 2.68M USD +184%
Liabilities, Current 5.1M USD +27%
Operating Lease, Liability, Noncurrent 2.11M USD -29.6%
Liabilities 7.22M USD +2.78%
Retained Earnings (Accumulated Deficit) -176M USD -43.8%
Stockholders' Equity Attributable to Parent 273M USD +3.46%
Liabilities and Equity 280M USD +3.44%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.5M USD -114%
Net Cash Provided by (Used in) Financing Activities 35K USD -28.6%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 45M shares +11.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -13.4M USD -115%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 286M USD +5.93%
Deferred Tax Assets, Valuation Allowance 38.2M USD +49.8%
Deferred Tax Assets, Gross 39.1M USD +46.7%
Operating Lease, Liability 3M USD -20.5%
Depreciation 13K USD +8.33%
Payments to Acquire Property, Plant, and Equipment 0 USD
Lessee, Operating Lease, Liability, to be Paid 3.48M USD -24.4%
Property, Plant and Equipment, Gross 214K USD +4.9%
Operating Lease, Liability, Current 889K USD +15%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.21M USD +2.64%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.18M USD +2.71%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 478K USD -42.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 238K USD -80.3%
Deferred Tax Assets, Operating Loss Carryforwards 15.1M USD +25.7%
Preferred Stock, Shares Issued 0 shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 238K USD -80.3%
Operating Lease, Payments 1.12M USD +35.1%
Additional Paid in Capital 448M USD +16.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 12.1M USD +33.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%